The latest call
FetchingClover Health Investments, Corp. reported on November 4, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
CLOV · Nasdaq · Healthcare · Healthcare Plans
$4.96+0.7%Nov 11 close
Figures through September 30, 2026, from the 10-Q filed November 6, 2026
Company outlook: revenue of $3B to $3B for Fiscal year 2026 — up 55.1% on a year earlier
Just reported
From Clover Health Investments, Corp.'s results release of November 4, 2026; its quarterly report has since been filed.
Actual
$759.3M
+53% y/y
+2.2% q/q
Guided
—
No guide given
Actual
$0.01
-80% q/q
Guided
—
No guide given
Actual
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $759.3M | $496.7M | +52.89% |
| Profit | $6.4M | -$24.4M | +126.40% |
| Profit per share | $0.01 | -$0.02 | +150.00% |
| Free Cash Flow | $69.5M | $11.4M | +508.89% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Clover Health Investments, Corp. reported on November 4, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Our results further demonstrate our technology-powered differentiation, and how earlier and better care management, market-leading growth, and increasing profitability can reinforce one another under the right model,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Financial Measures" below and in Appendix A. 2 Adjusted SG&A (Non-GAAP), Adjusted EBITDA (Non-GAAP), and Adjusted Net income (Non-GAAP) are Non-GAAP financial measures. Reconciliations of Adjusted SG&A (Non-GAAP) to SG&A, Adjusted EBITDA (Non-GAAP) to Net income, and Adjusted Net income (Non-GAAP) to Net income, respectively, the most directly comparable GAAP measures, are provided in the tables immediately following the consolidated financial statements below. Additional information about the Company's Non-GAAP financial measures can be found under the caption "
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Clover Health Investments, Corp.’s Item 2.02 8-K filed November 4, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
$6.4M
-77% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.